Corporate venturing describes, in legal practice, how an established company invests in or partners with start-ups and high‑growth businesses to advance its strategic objectives; this is often referred to as corporate
venture capital (CVC). It is not defined in legislation or case law, but is a descriptive term used across corporate, venture finance, M&A, competition and IP contexts.
Common structures include minority equity investments (from seed to late stage), joint ventures, strategic partnerships, incubators/accelerators, spin‑outs, and option or warrant arrangements. Documentation typically comprises subscription and shareholders’ agreements, setting governance, information and inspection rights, board or observer seats, reserved matters, anti‑dilution protections, commercial collaboration terms, exclusivity, rights of first negotiation/first refusal, and acquisition options.
Key legal issues include aligning strategic and financial returns, managing conflicts of interest, confidentiality and IP ownership/licensing, competition law constraints on information‑sharing, and exit rights. Transactions may engage merger control and foreign investment screening (for example, the UK National Security and Investment Act 2021 and, in Ireland, the Screening of Third Country Transactions Act 2023), and sector‑specific regulation.
Usage is broadly consistent across England & Wales, Scotland, Northern Ireland and Ireland, although company law mechanics and regulatory thresholds differ. Corporate venturing is distinct from purely financial venture capital, being...